Qualigen Therapeutics Inc.

NASDAQ: QLGN
Share price (10/2/25): $5.59
Market cap (10/2/25): $9.478 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Late annual filing notification for FY 2024

ended 09/30/24 Q3

Prospectuses and Registrations Filter

Registration withdrawal request

Initial registration of new securities

Exempt offering of securities

Initial registration of new securities

Exempt offering of securities

Ownership Filter

Alpha Capital Anstalt

Bensler Graydon

Lim Robert Bradley

Becher Campbell

News Filter

Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation Into Crypto

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) for Crypto Business Through PIPE Transaction

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Financial Statements or Exhibits

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness